| 
July
9, 2003 Issue 163
This
Week...
Over the past 2 months I have become even more involved
with children and Type 1 diabetes. With pump patients and
JDRF international Board involvement I have taken more notice
of what is available on the internet for kids and their
parents. A recent Internet search brought me to Fifty/50
a diabetes company that donates 50% of its profits to find
a cure. Learn more in my special feature. Click
here
Fred Pescatore, MD, MPH, CCN, finishes
his series on “Diseases Linked to Obesity and Insulin
Resistance” with Obesity:
Building A Program For Success
With only 4 weeks to go until AADE we want to remind you
that we will be in at Booth #1333, between
Roche, Aventis and Takeda. Please stop by to see our special
presentations.
Each week we will bring you nutritional information on
your patients favorite “fast foods”.
To see this weeks selections click
here.
Ethanol overdosage is the leading cause of death due to
low blood sugar in the United States. Dr. Evan Rosen,
M.D., Ph.D discusses why in Diabetes
and Drinking.
The Nutrition Concepts study is overfull. We are trying
to increase the number of participants. Please look for
an email soon if you are selected.
The Needle Disintegrator study is complete. We will have
results next week.
This week’s overview:
Item#1: Impaired Glucose
Tolerance Tied to Increased Risk of Cancer Mortality
Item:#2: Diabetes
Drugs Inappropriately Prescribed
Item #11: A Population
Perspective on Diabetes Prevention: Who Do We Target?
Check out this weeks “Test Your Knowledge”
question. Click Here
Dave
Joffe, Editor-in-Chief, CDE, FACA
Consider
making Diabetes in Control Your home page.
NewsFlash:
FDA Clears New Diabetes Device for Marketing—New
Minimed and Becton Dickinson product marries a glucose monitor
and insulin pump for improved patient care.
Diabetes In Control has learned that the new product will
be ready for shipment to patients on July 21st.
More...>
Statins Help People With Diabetes Even Without
High Cholesterol
The results from a 20,000 patient study suggest that most
patients with diabetes need to be on a statin to protect
them from heart disease People who have diabetes have an
increased risk of heart problems, yet they are not routinely
prescribed statins. See
Item#9

1. Impaired Glucose Tolerance Tied to Increased Risk of
Cancer Mortality
Click Here
2. Diabetes Drugs Inappropriately Prescribed
Click Here
3. Low-Glycemic-Index Mexican Diet Helpful in Obese Type
2 Diabetic Mexicans
Click Here
4. Effective Treatments Available for Diagnosed Diabetic
Neuropathy
Click Here
5. Regular Walking Decreases Morbidity Rate in Diabetics*
Click Here
6. Statins Cost-Effective for Diabetics With Mildly Elevated
LDL
Click Here
7. Poor Understanding of Disease Management Leads to Non-compliance
from Diabetics
Click Here
8. Long-term ACE Inhibitor Treatment Promotes Renal Health
and Improves Lipid Profiles
Click Here
9 LDL Cholesterol Reduction Beneficial For Diabetic Without
Coronary Disease
Click Here
10. Bacteria Could Help Failing Kidneys*
Click Here
11. A Population Perspective on Diabetes Prevention: Who
Do We Target?
Click Here
12. Lifestyle Intervention Reduced the Incidence of Diabetes
by 58%*
Click Here
13. Nurse Practitioner-Run Specialty Clinic May Prove Effective
in Type 2 Diabetes Management
Click Here
14. Glargine In Morning or Evening?*
Click Here
15. Pre-Diabetic Condition More Common in Obese Girls*
Click Here
Product
Update
A1cNow
is Now Over the Counter-No Prescription Needed!
Let
your Patients Check Their Own A1c Levels. It will motivate
to better control.
www.a1cnow.net
QUOTE OF THE WEEK
"Success
is not the result of spontaneous combustion. You must set
yourself on fire.”
Reggie Leach
Prescription
Drug Plan Faces Tests
Insurers' Participation Uncertain, Experts
Say
Congress's dramatic pre-dawn votes
on Friday to add prescription drug benefits to Medicare
were a political milestone, authorizing the biggest
expansion of the program since its birth. But health
policy analysts say that, even if the House and the
Senate are able to resolve differences between their
bills, it is far from certain the plan would work.
The drug coverage envisioned by Congress and the White
House relies on two kinds of private insurance methods:
separate policies solely for drugs, something that
does not currently exist, and preferred-provider networks,
a health plan that is common among younger people
but includes few Medicare patients. Read
More...>
|
|